Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman

PsA Perspectives - IL-23: Dr. Eric RudermanПодробнее

Measuring Disease Activity in Psoriatic Arthritis: Dr. Eric RudermanПодробнее

Axial Involvement in Psoriatic ArthritisПодробнее

RNL 2021 - Advancing Treatment in Psoriatic Arthritis - Dr. Eric RudermanПодробнее

Mid-Meeting Recap: Psoriatic ArthritisПодробнее

Dr. Eric Ruderman on New Mechanisms of Action on Psoriatic ArthritisПодробнее

Psoriatic Arthritis: What's with Brepocitinib? Dr. Eric RudermanПодробнее

A New Pathway in Psoriatic Arthritis: Dr. Eric RudermanПодробнее

Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric RudermanПодробнее

Tapering TNFi in Psoriatic Arthritis and Axial SpondyloarthritisПодробнее

Axial PsA: Is it for Real?Подробнее

Psoriatic Arthritis Panel DiscussionПодробнее

Should we treat to target in psoriatic arthritis?Подробнее

Psoriatic Arthritis and Guselkumab: Dr. Eric RudermanПодробнее

Recognizing and Treating Axial Disease in Psoriatic Arthritis: Dr. Pedro CastilloПодробнее

Pediatric Psoriatic Arthritis: Dr. Eric RudermanПодробнее

Panel Presentation: Psoriatic ArthritisПодробнее

Ixekizimab Withdrawal in PSA: Dr. Eric RudermanПодробнее

Importance of Central Imaging Reads in SpA: Dr. Eric RudermanПодробнее